(Q40620320)

22 September 2017

title

Lung cancer screening by spiral CT. What is the optimal target population for screening trials? (English)

1 reference

22 September 2017

4

Fred R Hirsch

1 reference

22 September 2017

Rob J van Klaveren

1

1 reference

22 September 2017

Harry J de Koning

series ordinal

2

1 reference

22 September 2017

James Mulshine

series ordinal

3

1 reference

22 September 2017

publication date

1 December 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

38

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

243-252

1 reference

Global cancer statistics in the year 2000.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Early Lung Cancer Action Project: overall design and findings from baseline screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer screening by low-dose spiral computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Epidemiology of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Incidence of lung cancer in Denmark: historical and actual status

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Recent trends in lung cancer mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

The epidemiology of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Mortality in relation to smoking: 20 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cigarette smoking and lung cancer in New Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Risk of Lung Cancer According to Histologic Type and Cigarette Dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer, smoking and diet among Swedish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cohort analysis of cigarette smoking and lung cancer incidence among Norwegian women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung carcinoma in former smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Patterns of Absolute Risk of Lung Cancer Mortality in Former Smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Decrease in risk of lung cancer death in males after smoking cessation by age at quitting: findings from the JACC study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer treated surgically in patients <50 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer in patients under 50 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Clinical strategies for solitary pulmonary nodule

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Breast cancer: age-specific growth rates and screening strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer in patients younger than 40 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cigarette Smoking and Mortality Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Recruitment of participants in the Lung Health Study, II: Assessment of recruiting strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Early detection of COPD in a high-risk population using spirometric screening

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Ten year follow-up of a comprehensive rehabilitation program for severe COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

BTS guidelines: guidelines on the selection of patients with lung cancer for surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Symptom-limited stair climbing as a predictor of postoperative cardiopulmonary complications after high-risk surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

A simple method to assess postoperative risk

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Estimation of ventilatory reserve by stair climbing. A study in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Preoperative assessment of the high-risk patient for lung resection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cancer screening in older patients: making decisions about age cutoffs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

The National Cancer Data Base report on lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Screening for lung cancer with low-dose spiral computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

The natural history of lung cancer estimated from the results of a randomized trial of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Cancer in the elderly: why so badly treated?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

Follow-up in lung cancer: how often and for what purpose?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900222-2

7 January 2021

10.1016/S0169-5002(02)00222-2

Identifiers

DOI

1 reference

22 September 2017

1 reference